Cargando…

Therapeutic effects of the mitochondrial ROS-redox modulator KH176 in a mammalian model of Leigh Disease

Leigh Disease is a progressive neurometabolic disorder for which a clinical effective treatment is currently still lacking. Here, we report on the therapeutic efficacy of KH176, a new chemical entity derivative of Trolox, in Ndufs4 (−/−) mice, a mammalian model for Leigh Disease. Using in vivo brain...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Haas, Ria, Das, Devashish, Garanto, Alejandro, Renkema, Herma G., Greupink, Rick, van den Broek, Petra, Pertijs, Jeanne, Collin, Rob W. J., Willems, Peter, Beyrath, Julien, Heerschap, Arend, Russel, Frans G., Smeitink, Jan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601915/ https://www.ncbi.nlm.nih.gov/pubmed/28916769 http://dx.doi.org/10.1038/s41598-017-09417-5

Ejemplares similares

Sonlicromanol’s active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth
por: Jiang, Xiaolan, et al.
Publicado: (2021)

KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery
por: Beyrath, Julien, et al.
Publicado: (2018)

Mechanism of action and potential applications of selective inhibition of microsomal prostaglandin E synthase-1-mediated PGE(2) biosynthesis by sonlicromanol’s metabolite KH176m
por: Jiang, X., et al.
Publicado: (2021)

The Redox Modulating Sonlicromanol Active Metabolite KH176m and the Antioxidant MPG Protect Against Short-Duration Cardiac Ischemia-Reperfusion Injury
por: Xiao, Yang, et al.
Publicado: (2021)

The KHENERGY Study: Safety and Efficacy of KH176 in Mitochondrial m.3243A>G Spectrum Disorders
por: Janssen, Mirian C.H., et al.
Publicado: (2018)

KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers
por: Koene, Saskia, et al.
Publicado: (2017)

Rescue from galactose-induced death of Leigh Syndrome patient cells by pyruvate and NAD(+)
por: Iannetti, Eligio F., et al.
Publicado: (2018)

Live-Imaging Readouts and Cell Models for Phenotypic Profiling of Mitochondrial Function
por: Iannetti, Eligio F., et al.
Publicado: (2019)

Mitochondrial ADP/ATP exchange inhibition: a novel off-target mechanism underlying ibipinabant-induced myotoxicity
por: Schirris, Tom J. J., et al.
Publicado: (2015)

A Drosophila Mitochondrial Complex I Deficiency Phenotype Array
por: Foriel, Sarah, et al.
Publicado: (2019)

Toxicity of anticancer drugs in human placental tissue explants and trophoblast cell lines
por: Eliesen, Gaby A. M., et al.
Publicado: (2020)

A randomised placebo-controlled, double-blind phase II study to explore the safety, efficacy, and pharmacokinetics of sonlicromanol in children with genetically confirmed mitochondrial disease and motor symptoms (“KHENERGYC”)
por: Smeitink, Jan, et al.
Publicado: (2022)

Physiologically Based Modelling of Darunavir/Ritonavir Pharmacokinetics During Pregnancy
por: Colbers, Angela, et al.
Publicado: (2015)

Sonlicromanol improves neuronal network dysfunction and transcriptome changes linked to m.3243A>G heteroplasmy in iPSC-derived neurons
por: Klein Gunnewiek, Teun M., et al.
Publicado: (2021)

Assessment of Placental Disposition of Infliximab and Etanercept in Women With Autoimmune Diseases and in the Ex Vivo Perfused Placenta
por: Eliesen, Gaby A. M., et al.
Publicado: (2020)

Dr. Leigh H. Hunt
Publicado: (1883)

IMP1 KH1 and KH2 domains create a structural platform with unique RNA recognition and re-modelling properties
por: Dagil, Robert, et al.
Publicado: (2019)

Mitochondrial disorders in children: toward development of small‐molecule treatment strategies
por: Koopman, Werner JH, et al.
Publicado: (2016)

Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically‐Based Pharmacokinetic Modeling
por: Freriksen, Jolien J.M., et al.
Publicado: (2020)

Subject index for volume 176
Publicado: (1990)

Mitochondrial Migraine: Disentangling the angiopathy paradigm in m.3243A>G patients
por: Smeitink, Jan, et al.
Publicado: (2019)

Los sueños de Heaven Leigh /
por: Andrews, V. C. (Virginia C.)
Publicado: (1987)

Leigh's disease involving multiple organs.
por: Jung, K. C., et al.
Publicado: (1993)

An interesting case of Leigh-like syndrome
por: Bharani, K., et al.
Publicado: (2012)

Leigh syndrome with atypical cerebellar lesions
por: Veiga, Marcos Gil Alberto da, et al.
Publicado: (2019)

MELAS or Leigh syndrome, that’s the question
por: Finsterer, Josef
Publicado: (2021)

Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic Modeling
por: Schalkwijk, Stein, et al.
Publicado: (2017)

Polarization mechanism and ferroelectric instabilityin $KH_{2}PO_{4}$
por: Koval, S, et al.
Publicado: (2000)

Protective Effects of KH-204 in the Bladder of Androgen-Deprived Rats
por: Bae, Woong Jin, et al.
Publicado: (2015)

Placental disposition of eculizumab, C5 and C5‐eculizumab in two pregnancies of a woman with paroxysmal nocturnal haemoglobinuria
por: Eliesen, Gaby A.M., et al.
Publicado: (2020)

Health Tract, No. 176: Posture in Worship
Publicado: (1863)

Health Tract, No. 176: Posture in Worship
Publicado: (1865)

Cinical, Metabolic, and Genetic Analysis and Follow-Up of Eight Patients With HIBCH Mutations Presenting With Leigh/Leigh-Like Syndrome
por: Wang, Junling, et al.
Publicado: (2021)

Modeling mitochondrial dysfunctions in the brain: from mice to men
por: Breuer, Megan E., et al.
Publicado: (2011)

To be or not to be pink(1): contradictory findings in an animal model for Parkinson’s disease
por: de Haas, Ria, et al.
Publicado: (2019)

Leigh syndrome: MRI findings in two children
por: Kartikasalwah, AL, et al.
Publicado: (2010)

Epilepsy in Leigh Syndrome With Mitochondrial DNA Mutations
por: Lee, Sunho, et al.
Publicado: (2019)

Why does Leigh syndrome respond to immunotherapy?
por: Finsterer, Josef, et al.
Publicado: (2016)

Leigh Syndrome with atypical cerebellum imaging features
por: da Veiga, Marcos Gil Alberto, et al.
Publicado: (2019)

Leigh syndrome associated with TRMU gene mutations
por: Sala-Coromina, Júlia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ar11fq4j4ovmjulobjgsh9d2ak